PubMed:32031570 / 1985-2212 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T8 42-53 CHEBI:7798 denotes oseltamivir
T9 42-53 CHEBI:7798 denotes oseltamivir
T10 110-122 CHEBI:63611 denotes moxifloxacin
T11 110-122 CHEBI:63611 denotes moxifloxacin
T12 136-147 CHEBI:29007 denotes ceftriaxone
T13 136-147 CHEBI:29007 denotes ceftriaxone
T14 161-173 CHEBI:2955 denotes azithromycin
T15 161-173 CHEBI:2955 denotes azithromycin
T16 161-173 DG_6 denotes azithromycin
T17 191-205 CHEBI:24261 denotes glucocorticoid
T18 191-205 CHEBI:24261 denotes glucocorticoid

LitCovid-PAS-Enju

Id Subject Object Predicate Lexical cue
EnjuParser_T360 0-4 JJS denotes Most
EnjuParser_T361 5-13 NNS denotes patients
EnjuParser_T362 14-22 VBD denotes received
EnjuParser_T363 23-32 JJ denotes antiviral
EnjuParser_T364 33-40 NN denotes therapy
EnjuParser_T365 41-42 -LRB- denotes (
EnjuParser_T366 42-53 NN denotes oseltamivir
EnjuParser_T367 53-54 -COMMA- denotes ,
EnjuParser_T368 55-58 CD denotes 124
EnjuParser_T369 59-60 -LRB- denotes [
EnjuParser_T370 60-64 CD denotes 89.9
EnjuParser_T371 64-65 NN denotes %
EnjuParser_T372 65-66 -RRB- denotes ]
EnjuParser_T373 66-67 -RRB- denotes )
EnjuParser_T374 67-68 -COMMA- denotes ,
EnjuParser_T375 69-72 CC denotes and
EnjuParser_T376 73-77 JJ denotes many
EnjuParser_T377 78-86 VBD denotes received
EnjuParser_T378 87-100 JJ denotes antibacterial
EnjuParser_T379 101-108 NN denotes therapy
EnjuParser_T380 109-110 -LRB- denotes (
EnjuParser_T381 110-122 NN denotes moxifloxacin
EnjuParser_T382 122-123 -COMMA- denotes ,
EnjuParser_T383 124-126 CD denotes 89
EnjuParser_T384 127-128 -LRB- denotes [
EnjuParser_T385 128-132 CD denotes 64.4
EnjuParser_T386 132-133 NN denotes %
EnjuParser_T387 133-134 -RRB- denotes ]
EnjuParser_T388 134-135 -SEMICOLON- denotes ;
EnjuParser_T389 136-147 NN denotes ceftriaxone
EnjuParser_T390 147-148 -COMMA- denotes ,
EnjuParser_T391 149-151 CD denotes 34
EnjuParser_T392 152-153 -LRB- denotes [
EnjuParser_T393 153-157 CD denotes 24.6
EnjuParser_T394 157-158 NN denotes %
EnjuParser_T395 158-159 -RRB- denotes ]
EnjuParser_T396 159-160 -SEMICOLON- denotes ;
EnjuParser_T397 161-173 NN denotes azithromycin
EnjuParser_T398 173-174 -COMMA- denotes ,
EnjuParser_T399 175-177 CD denotes 25
EnjuParser_T400 178-179 -LRB- denotes [
EnjuParser_T401 179-183 CD denotes 18.1
EnjuParser_T402 183-184 NN denotes %
EnjuParser_T403 184-185 -RRB- denotes ]
EnjuParser_T404 185-186 -RRB- denotes )
EnjuParser_T405 187-190 CC denotes and
EnjuParser_T406 191-205 NN denotes glucocorticoid
EnjuParser_T407 206-213 NN denotes therapy
EnjuParser_T408 214-215 -LRB- denotes (
EnjuParser_T409 215-217 CD denotes 62
EnjuParser_T410 218-219 -LRB- denotes [
EnjuParser_T411 219-223 CD denotes 44.9
EnjuParser_T412 223-224 NN denotes %
EnjuParser_T413 224-225 -RRB- denotes ]
EnjuParser_T414 225-226 -RRB- denotes )
EnjuParser_R358 EnjuParser_T361 EnjuParser_T360 arg1Of patients,Most
EnjuParser_R359 EnjuParser_T361 EnjuParser_T362 arg1Of patients,received
EnjuParser_R360 EnjuParser_T364 EnjuParser_T362 arg2Of therapy,received
EnjuParser_R361 EnjuParser_T364 EnjuParser_T363 arg1Of therapy,antiviral
EnjuParser_R362 EnjuParser_T364 EnjuParser_T365 arg1Of therapy,(
EnjuParser_R363 EnjuParser_T366 EnjuParser_T365 arg2Of oseltamivir,(
EnjuParser_R364 EnjuParser_T373 EnjuParser_T365 arg3Of ),(
EnjuParser_R365 EnjuParser_T366 EnjuParser_T367 arg1Of oseltamivir,","
EnjuParser_R366 EnjuParser_T368 EnjuParser_T367 arg2Of 124,","
EnjuParser_R367 EnjuParser_T368 EnjuParser_T369 arg1Of 124,[
EnjuParser_R368 EnjuParser_T371 EnjuParser_T369 arg2Of %,[
EnjuParser_R369 EnjuParser_T372 EnjuParser_T369 arg3Of ],[
EnjuParser_R370 EnjuParser_T371 EnjuParser_T370 arg1Of %,89.9
EnjuParser_R371 EnjuParser_T375 EnjuParser_T374 arg1Of and,","
EnjuParser_R372 EnjuParser_T362 EnjuParser_T375 arg1Of received,and
EnjuParser_R373 EnjuParser_T377 EnjuParser_T375 arg2Of received,and
EnjuParser_R374 EnjuParser_T376 EnjuParser_T377 arg1Of many,received
EnjuParser_R375 EnjuParser_T405 EnjuParser_T377 arg2Of and,received
EnjuParser_R376 EnjuParser_T379 EnjuParser_T378 arg1Of therapy,antibacterial
EnjuParser_R377 EnjuParser_T379 EnjuParser_T380 arg1Of therapy,(
EnjuParser_R378 EnjuParser_T381 EnjuParser_T380 arg2Of moxifloxacin,(
EnjuParser_R379 EnjuParser_T404 EnjuParser_T380 arg3Of ),(
EnjuParser_R380 EnjuParser_T381 EnjuParser_T382 arg1Of moxifloxacin,","
EnjuParser_R381 EnjuParser_T383 EnjuParser_T382 arg2Of 89,","
EnjuParser_R382 EnjuParser_T383 EnjuParser_T384 arg1Of 89,[
EnjuParser_R383 EnjuParser_T386 EnjuParser_T384 arg2Of %,[
EnjuParser_R384 EnjuParser_T387 EnjuParser_T384 arg3Of ],[
EnjuParser_R385 EnjuParser_T386 EnjuParser_T385 arg1Of %,64.4
EnjuParser_R386 EnjuParser_T381 EnjuParser_T388 arg1Of moxifloxacin,;
EnjuParser_R387 EnjuParser_T389 EnjuParser_T388 arg2Of ceftriaxone,;
EnjuParser_R388 EnjuParser_T389 EnjuParser_T390 arg1Of ceftriaxone,","
EnjuParser_R389 EnjuParser_T391 EnjuParser_T390 arg2Of 34,","
EnjuParser_R390 EnjuParser_T391 EnjuParser_T392 arg1Of 34,[
EnjuParser_R391 EnjuParser_T394 EnjuParser_T392 arg2Of %,[
EnjuParser_R392 EnjuParser_T395 EnjuParser_T392 arg3Of ],[
EnjuParser_R393 EnjuParser_T394 EnjuParser_T393 arg1Of %,24.6
EnjuParser_R394 EnjuParser_T381 EnjuParser_T396 arg1Of moxifloxacin,;
EnjuParser_R395 EnjuParser_T397 EnjuParser_T396 arg2Of azithromycin,;
EnjuParser_R396 EnjuParser_T397 EnjuParser_T398 arg1Of azithromycin,","
EnjuParser_R397 EnjuParser_T399 EnjuParser_T398 arg2Of 25,","
EnjuParser_R398 EnjuParser_T399 EnjuParser_T400 arg1Of 25,[
EnjuParser_R399 EnjuParser_T402 EnjuParser_T400 arg2Of %,[
EnjuParser_R400 EnjuParser_T403 EnjuParser_T400 arg3Of ],[
EnjuParser_R401 EnjuParser_T402 EnjuParser_T401 arg1Of %,18.1
EnjuParser_R402 EnjuParser_T379 EnjuParser_T405 arg1Of therapy,and
EnjuParser_R403 EnjuParser_T407 EnjuParser_T405 arg2Of therapy,and
EnjuParser_R404 EnjuParser_T407 EnjuParser_T406 arg1Of therapy,glucocorticoid
EnjuParser_R405 EnjuParser_T407 EnjuParser_T408 arg1Of therapy,(
EnjuParser_R406 EnjuParser_T409 EnjuParser_T408 arg2Of 62,(
EnjuParser_R407 EnjuParser_T414 EnjuParser_T408 arg3Of ),(
EnjuParser_R408 EnjuParser_T409 EnjuParser_T410 arg1Of 62,[
EnjuParser_R409 EnjuParser_T412 EnjuParser_T410 arg2Of %,[
EnjuParser_R410 EnjuParser_T413 EnjuParser_T410 arg3Of ],[
EnjuParser_R411 EnjuParser_T412 EnjuParser_T411 arg1Of %,44.9

LitCovid-ArguminSci

Id Subject Object Predicate Lexical cue
T11 0-227 DRI_Background denotes Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]).

LitCovid-OGER

Id Subject Object Predicate Lexical cue
T2 42-53 CHEBI:7798 denotes oseltamivir
T3 110-122 CHEBI:63611 denotes moxifloxacin
T4 136-147 CHEBI:29007 denotes ceftriaxone
T5 161-173 CHEBI:2955 denotes azithromycin
T6 191-205 CHEBI:24261 denotes glucocorticoid

LitCovid-PubTatorCentral

Id Subject Object Predicate Lexical cue
T26 5-13 Species:9606 denotes patients
T27 42-53 Chemical:MESH:D053139 denotes oseltamivir
T28 110-122 Chemical:MESH:C104727 denotes moxifloxacin
T29 136-147 Chemical:MESH:D002443 denotes ceftriaxone
T30 161-173 Chemical:MESH:D017963 denotes azithromycin

LitCovid-sentences-v1

Id Subject Object Predicate Lexical cue
TextSentencer_T21 0-227 Sentence denotes Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]).

LitCovid-TimeML

Id Subject Object Predicate Lexical cue
tok421 0-4 JJS denotes Most
tok422 5-13 NNS denotes patients
tok423 14-22 VBD denotes received
tok424 23-32 JJ denotes antiviral
tok425 33-40 NN denotes therapy
tok426 41-42 ( denotes (
tok427 42-53 NN denotes oseltamivir
tok428 53-54 , denotes ,
tok429 55-58 CD denotes 124
tok430 59-60 NN denotes [
tok431 60-62 CD denotes 89
tok432 62-63 . denotes .
tok433 63-64 CD denotes 9
tok434 64-65 NN denotes %
tok435 65-66 NN denotes ]
tok436 66-67 ) denotes )
tok437 67-68 , denotes ,
tok438 69-72 CC denotes and
tok439 73-77 JJ denotes many
tok440 78-86 JJ denotes received
tok441 87-100 NN denotes antibacterial
tok442 101-108 NN denotes therapy
tok443 109-110 ( denotes (
tok444 110-122 NN denotes moxifloxacin
tok445 122-123 , denotes ,
tok446 124-126 CD denotes 89
tok447 127-128 NN denotes [
tok448 128-130 CD denotes 64
tok449 130-131 . denotes .
tok450 131-132 CD denotes 4
tok451 132-133 NN denotes %
tok452 133-134 NN denotes ]
tok453 134-135 : denotes ;
tok454 136-147 NN denotes ceftriaxone
tok455 147-148 , denotes ,
tok456 149-151 CD denotes 34
tok457 152-153 NN denotes [
tok458 153-155 CD denotes 24
tok459 155-156 . denotes .
tok460 156-157 CD denotes 6
tok461 157-158 NN denotes %
tok462 158-159 NN denotes ]
tok463 159-160 : denotes ;
tok464 161-173 NN denotes azithromycin
tok465 173-174 , denotes ,
tok466 175-177 CD denotes 25
tok467 178-179 NN denotes [
tok468 179-181 CD denotes 18
tok469 181-182 . denotes .
tok470 182-183 CD denotes 1
tok471 183-184 NN denotes %
tok472 184-185 NN denotes ]
tok473 185-186 ) denotes )
tok474 187-190 CC denotes and
tok475 191-205 NN denotes glucocorticoid
tok476 206-213 NN denotes therapy
tok477 214-215 ( denotes (
tok478 215-217 CD denotes 62
tok479 218-219 NN denotes [
tok480 219-221 CD denotes 44
tok481 221-222 . denotes .
tok482 222-223 CD denotes 9
tok483 223-224 NN denotes %
tok484 224-225 NN denotes ]
tok485 225-226 ) denotes )
tok486 226-227 . denotes .
lookup49 64-65 percent denotes %
lookup50 132-133 percent denotes %
lookup51 157-158 percent denotes %
lookup52 183-184 percent denotes %
lookup53 223-224 percent denotes %
event14 14-22 OCCURRENCE denotes received

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T9 149-151 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 23-32 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T3 42-53 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T4 110-122 Chemical denotes moxifloxacin http://purl.obolibrary.org/obo/CHEBI_63611
T5 136-147 Chemical denotes ceftriaxone http://purl.obolibrary.org/obo/CHEBI_29007
T6 161-173 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T7 191-205 Chemical denotes glucocorticoid http://purl.obolibrary.org/obo/CHEBI_24261

MeasurableQuantitativeAnnotation

Id Subject Object Predicate Lexical cue
E1 23-40 entity denotes antiviral therapy
E2 42-53 entity denotes oseltamivir
E3 87-108 entity denotes antibacterial therapy
E4 110-122 entity denotes moxifloxacin
N1 55-58 num denotes 124
N2 60-64 num denotes 89.9
N3 124-126 num denotes 89
N4 128-132 num denotes 64.4
U1 64-65 unit denotes %
U2 132-133 unit denotes %
E1 136-147 entity denotes ceftriaxone
N1 149-151 num denotes 34
N2 153-157 num denotes 24.6
U1 157-158 unit denotes %
E1 161-173 entity denotes azithromycin
E2 191-213 entity denotes glucocorticoid therapy
N1 175-177 num denotes 25
N2 179-183 num denotes 18.1
N3 215-217 num denotes 62
N4 219-223 num denotes 44.9
U1 183-184 unit denotes %
U2 223-224 unit denotes %

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
73 5-13 Species denotes patients Tax:9606
74 42-53 Chemical denotes oseltamivir MESH:D053139
75 110-122 Chemical denotes moxifloxacin MESH:D000077266
76 136-147 Chemical denotes ceftriaxone MESH:D002443
77 161-173 Chemical denotes azithromycin MESH:D017963

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T21 0-227 Sentence denotes Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]).